Aluminium
[2009 Nov] Researcher's labour of love leads
to MS breakthrough
Are researchers ignorant to the fact that aluminum causes
hemochromatosis?
From: Teresa Binstock <binstock@peakpeak.com>
Re: ot with iron & MS: Researcher's labour of love leads to MS break
Posted by: "Liz"
elizabethsoliday@yahoo.com elizabethsoliday
Date: Mon Nov 30, 2009 7:12 am ((PST))
Do you ever wonder, Teresa, if these researchers are actually ignorant to the
fact that aluminum causes hemochromatosis (iron overload) or do you think they
are purposely hiding the truth?
I have not been aware than "aluminum causes hemochromatosis". Pubmed was not
helpful. The search hemochromatosis AND aluminum
generated 9 citations.
1: Szwarcberg J, Mack G, Flament J. [Ocular toxicity of deferoxamine:
description
and analysis of three observations]. J Fr Ophtalmol. 2002 Jun;25(6):609-14.
French. PubMed PMID: 12223949.
2: McNab AA, McKelvie P. Iron overload is a risk factor for zygomycosis. Arch
Ophthalmol. 1997 Jul;115(7):919-21. PubMed PMID: 9230837.
3: Swartz RD, Legault DJ. Long-term intraperitoneal deferoxamine for
hemochromatosis. Am J Med. 1996 Mar;100(3):308-12. PubMed PMID: 8629676.
4: Iancu TC, Perl DP, Sternlieb I, Lerner A, Leshinsky E, Kolodny EH, Hsu A,
Good
PF. The application of laser microprobe mass analysis to the study of biological
material. Biometals. 1996 Jan;9(1):57-65. PubMed PMID: 8574093.
5: Oshiro S. [A new inducible transferrin-independent iron uptake system
involved
with aluminum accumulation in the brain of patients with Alzheimer's disease].
Tanpakushitsu Kakusan Koso. 1995 Aug;40(11):1738-43. Review. Japanese. PubMed
PMID: 7676035.
6: el-Reshaid K, Johny KV, Hakim A, Kamel H, Sebeta A, Hourani H, Kanyike FB.
Erythropoietin treatment in haemodialysis patients with iron overload. Acta
Haematol. 1994;91(3):130-5. PubMed PMID: 8091934.
7: Rosenlöf K, Grönhagen-Riska C, Sovijärvi A, Honkanen E, Tikkanen I, Ekstrand
A, Piirilä P, Fyhrquist F. Beneficial effects of erythropoietin on
haematological
parameters, aerobic capacity, and body fluid composition in patients on
haemodialysis. J Intern Med. 1989 Nov;226(5):311-7. PubMed PMID: 2809506.
8: Allain P, Mauras Y, Chaleil D, Simon P, Ang KS, Cam G, Le Mignon L, Simon M.
Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in
healthy subjects and patients with haemochromatosis. Br J Clin Pharmacol. 1987
Aug;24(2):207-12. PubMed PMID: 3620295; PubMed Central PMCID: PMC1387751.
9: Braunstein EM, Menerey K, Martel W, Swartz R, Fox IH. Radiologic features of
a
pyrophosphate-like arthropathy associated with long-term dialysis. Skeletal
Radiol. 1987;16(6):437-41. PubMed PMID: 2821626.